Trial Profile
A Phase II Trial Of Imatinib Mesylate (Gleevec) In Patients With HIV Related Kaposi's Sarcoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 17 Dec 2009 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2007 Status changed from recruiting to in progress.